Trial intelligence / Profile preview

MK-0431/ONO-5435 add-on to metformin in type 2 diabetes mellitus

jRCT2080220287Phase 3

Sponsor
Ono Pharmaceutical
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Ono Pharmaceutical.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080220287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call